Moxifloxacin: safety profile
The latest, so-called respiratory, fluoroquinolones are a group of antimicrobial agents (AMA), most commonly prescribed for community-acquired lower respiratory tract infection (caLRTI), which is a relevant issue in routine clinical practice.
Hlavní autor: | A. I. Sinopalnikov |
---|---|
Médium: | Článek |
Jazyk: | Russian |
Vydáno: |
Remedium Group LLC
2013-12-01
|
Edice: | Медицинский совет |
Témata: | |
On-line přístup: | https://www.med-sovet.pro/jour/article/view/1152 |
Podobné jednotky
-
Community-acquired pneumonia against a background of chronic heart failure: diagnosis and treatment
Autor: A. A. Bobylev, a další
Vydáno: (2014-12-01) -
Moxifloxacin in the treatment of community-acquired pneumonia in adults: what's new?
Autor: A. I. Sinopalnikov
Vydáno: (2014-12-01) -
Rational therapy of patients with lower respiratory tract infections
Autor: V. A. Kazantsev
Vydáno: (2013-12-01) -
Cough in children as a symptom of respiratory tract infections: a new look at the problem of antibiotic therapy
Autor: O. A. Egorova
Vydáno: (2014-12-01) -
Местная иммуномодуляция при заболеваниях верхних дыхательных путей
Vydáno: (2018-06-01)